Wealth Enhancement Advisory Services
DAWN

Wealth Enhancement Advisory Services’s Day One Biopharmaceuticals DAWN Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,812
Closed -$339K – 4162
2026
Q1 		$339K Buy
+15,812
New +$223K ﹤0.01% 2657
2025
Q3 		– Sell
-10,262
Closed -$69.8K – 3619
2025
Q2 		$69.8K Sell
10,262
-892
-8% -$6.14K ﹤0.01% 3187
2025
Q1 		$88.5K Buy
+11,154
New +$120K ﹤0.01% 2785

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wealth Enhancement Advisory Services's DAWN Position: Q2 2026 in Review

Wealth Enhancement Advisory Services sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 15,812 shares — an estimated $339K sold.

Wealth Enhancement Advisory Services first reported a position in DAWN in Q1 2025 and held it in 3 quarters. The position peaked at $339K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Wealth Enhancement Advisory Services reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 15,812 Day One Biopharmaceuticals shares in Q2 2026, an estimated $339K.
  • Wealth Enhancement Advisory Services first reported a position in Day One Biopharmaceuticals in Q1 2025 and held it in 3 quarters.
  • Wealth Enhancement Advisory Services's Day One Biopharmaceuticals position peaked at $339K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.